6533b871fe1ef96bd12d1a69
RESEARCH PRODUCT
Prevalence of Hepatitis B Virus Markers in Patients with Autoimmune Inflammatory Rheumatic Diseases in Italy
Tommaso StroffoliniMarco CanzoniIrene ModestoBruno LaganàPaola ConigliaroEleonora CellettiClaudia FerlitoRoberta Di RosaVincenzo ColonnaSimonetta SalemiRaffaele D'amelioMichela Ileen BiondoMaria Laura SorgiMario Stefano PeragalloFrancesca Della CasaAndrea Picchianti-diamantiPaola BeginiMassimo MarignaniCinzia MarreseS. Caporusciosubject
0301 basic medicineMicrobiology (medical)HBsAgmedicine.medical_specialtyimmunosuppressive therapyHbv markersmedicine.disease_causeMicrobiologyGastroenterologyArticleVirus03 medical and health sciences0302 clinical medicineVirologyInternal medicinemedicineIn patientlcsh:QH301-705.5Hepatitis B virusbusiness.industryrheumatic patientsvirus diseasesHBV vaccineHBV markersmedicine.diseaseConnective tissue diseasedigestive system diseasesVaccinationTiter030104 developmental biologylcsh:Biology (General)030211 gastroenterology & hepatologybusinessHBV markers; HBV vaccine; immunosuppressive therapy; rheumatic patientsdescription
Chronic hepatitis B virus (HBV) infection may be reactivated by immunosuppressive drugs in patients with autoimmune inflammatory rheumatic diseases. This study evaluates HBV serum markers&rsquo
year | journal | country | edition | language |
---|---|---|---|---|
2020-11-16 | Microorganisms |